161 related articles for article (PubMed ID: 33310279)
1. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta-analysis.
Mohammadi C; Gholamzadeh Khoei S; Fayazi N; Mohammadi Y; Najafi R
Crit Rev Oncol Hematol; 2021 Jan; 157():103183. PubMed ID: 33310279
[TBL] [Abstract][Full Text] [Related]
2. LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis.
Lin P; Xing W; Ren Q; Wang Q; Yan J; Mao G
Front Oncol; 2022; 12():767750. PubMed ID: 35692742
[TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
4. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
5. LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis.
Xie Y; Han J; Xie K; Gou Q
Sci Rep; 2022 Nov; 12(1):18494. PubMed ID: 36323697
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing.
Li G; Qiu Y; Su Z; Ren S; Liu C; Tian Y; Liu Y
PLoS One; 2013; 8(12):e84486. PubMed ID: 24367666
[TBL] [Abstract][Full Text] [Related]
7. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
[No Abstract] [Full Text] [Related]
8. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
[TBL] [Abstract][Full Text] [Related]
11. miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.
Huang Y; Tan D; Xiao J; Li Q; Zhang X; Luo Z
J Cancer Res Ther; 2018 Jan; 14(1):111-118. PubMed ID: 29516971
[TBL] [Abstract][Full Text] [Related]
12. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; De Ieso P; Gee H; Moss SA; Milic N
Dis Markers; 2018; 2018():8309015. PubMed ID: 30538784
[TBL] [Abstract][Full Text] [Related]
14. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN.
Qu C; Liang Z; Huang J; Zhao R; Su C; Wang S; Wang X; Zhang R; Lee MH; Yang H
Cell Cycle; 2012 Feb; 11(4):785-96. PubMed ID: 22374676
[TBL] [Abstract][Full Text] [Related]
15. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
[TBL] [Abstract][Full Text] [Related]
16. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; Gee H; Milic N
Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
[TBL] [Abstract][Full Text] [Related]
18. A new biomarker to enhance the radiosensitivity of hepatocellular cancer: miRNAs.
Guo J; Jin K; Tang T; Liu HM; Xie YA
Future Oncol; 2022 Sep; 18(28):3217-3228. PubMed ID: 35968820
[TBL] [Abstract][Full Text] [Related]
19. miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Luo M; Ding L; Li Q; Yao H
Breast Cancer; 2017 Sep; 24(5):673-682. PubMed ID: 28138801
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
Li G; Liu Y; Su Z; Ren S; Zhu G; Tian Y; Qiu Y
Eur J Cancer; 2013 Jul; 49(11):2596-607. PubMed ID: 23583221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
